First Report Managed Care
December 27, 2024
"Looking ahead to 2025, opportunities will increase with new developments in liquid biopsy tests that detect circulating cancer DNA cells and monitor cancer progression, treatment efficacy, and recurrence. Simple blood tests conducted over time will allow noninvasive, more precise insights for detecting multiple cancers at early stages and help inform treatment decisions." - Joel Diamond, MD
Click here to read "2024 Trends and 2025 Predictions: Insights From Health Care Leaders on Advancing Medicare, AI Solutions, and Clinical Data Utilization."